Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States
Clinical trial NCT03353480 · COMPLETED
Trial details
- NCT number
- NCT03353480
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2018-01-29
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.